Placement Announced
Chimeric Therapeutics placement (May 2025)
A$6.6m raised
Announced 20 May 2025 · ASX: CHM
Advisers
Chimeric Therapeutics
Issuer
Not disclosed
Lead managers
- Joint lead manager
- Issuer
- Chimeric Therapeutics
- Issuer based in
- Australia
- Sector
- Biotech
- Tags
- Biotech, Cell Therapy, Oncology
Similar deals
- Liminatus Pharma equity raising Feb 2026 · A$5.7m · Biotech
- Obsidian Therapeutics placement Apr 2026 · A$498m · Biotech
- Silexion Therapeutics Corp equity raising A$3.6m · Biotech
- Imugene placement (March 2026) Mar 2026 · A$20m · Biotech
- AdAlta placement (January 2026) Jan 2026 · A$1.2m · Biotech
Sources
- 20 May 2025 $6.6 million Placement to advance clinical trial pipeline ASX
